Buffered Saline

DEVICE2 trials

Sponsors

Ferring Pharmaceuticals, AIM Therapeutics Inc.

Conditions

AsthmaOsteoarthritis of the Knee

Phase 2

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

CompletedNCT01501942

AIM Therapeutics Inc.Asthma

Start: 2012-02-29End: 2013-03-31Updated: 2014-02-14

Phase 3

Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee

CompletedNCT00988091

Ferring PharmaceuticalsOsteoarthritis of the Knee

Start: 2009-09-30End: 2011-04-30Updated: 2012-06-15